The same study further showed that silencing or pharmacological inhibition of BMAL1 induced a wide range of interferon-stimulated genes which possess a broad activity against many viruses [18], suggesting that targeting host clock proteins may be a possible approach to limiting not only SARS-CoV-2 but other viral infection. This evidence concerns the gene CLOCK and viral infectious disease.